APPEARANCE OF ANTICOAGULANT FACTORS AND CERTAIN AUTOIMMUNE ANTIBODIES FOLLOWING ANTIGENIC STIMULATION WITH BLOOD GROUP SUBSTANCES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：40
|
作者：
ZINGALE, SB
ANDRADA, JA
SANCHEZAVALOS, JC
STRINGA, SG
MANNI, JA
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1963年 / 6卷 / 05期
关键词：
D O I：
10.1002/art.1780060503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：581 / +
页数：1
相关论文
共 50 条
  • [21] ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF 3 LUPUS ANTICOAGULANT ASSAYS AND ANTICARDIOLIPIN ELISA IN 188 PATIENTS
    JOUHIKAINEN, T
    JULKUNEN, H
    VAARALA, O
    LEIRISALOREPO, M
    STEPHANSSON, E
    VAHTERA, E
    PALOSUO, T
    MYLLYLA, G
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 407 - 414
  • [22] THYMOCYTOTOXIC ANTIBODIES IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC-ANEMIA SYSTEMIC LUPUS-ERYTHEMATOSUS AND LYMPHOPROLIFERATIVE DISEASES
    FAGIOLO, E
    BLUT, 1982, 44 (04): : 225 - 230
  • [23] LYMPHOCYTOTOXIC ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS AND THEIR RELATIVES - REACTIVITY WITH THE HLA ANTIGENIC MOLECULAR-COMPLEX
    MESSNER, RP
    DEHORATIUS, R
    FERRONE, S
    ARTHRITIS AND RHEUMATISM, 1980, 23 (03): : 265 - 272
  • [24] ANTI-CYTOPLASMIC FACTORS IN THE SERA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND CERTAIN OTHER DISEASES
    DEICHER, HRG
    HOLMAN, HR
    KUNKEL, HG
    ARTHRITIS AND RHEUMATISM, 1960, 3 (01): : 1 - 15
  • [25] Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus (SLE) in Jamaica
    Chambers, Sharon A.
    Raine, Rosalind
    Rahman, Anisur
    De Ceulaer, Karel
    Hagley, Karlene
    Isenberg, David
    RHEUMATOLOGY, 2008, 47 : II93 - II93
  • [26] Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis
    Swadzba, J
    DeClerck, LS
    Stevens, WJ
    Bridts, CH
    vanCotthem, KA
    Musial, J
    Jankowski, M
    Szczeklik, A
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (09) : 1710 - 1715
  • [27] Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
    Nojima, J
    Kuratsune, H
    Suehisa, E
    Futsukaichi, Y
    Yamanishi, H
    Machii, T
    Kitani, T
    Iwatani, Y
    Kanakura, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 647 - 654
  • [28] DYSLIPIDAEMIA, HYPERHOMOCYSTEINAEMIA AND ANTIPHOSPHOLIPID ANTIBODIES AS RISK FACTORS OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Shevchuk, Sergii
    Segeda, Iuliia
    RHEUMATOLOGY, 2011, 50 : 106 - 106
  • [29] Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies?
    Mok, MY
    Farewell, VT
    Isenberg, DA
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (06) : 462 - 467
  • [30] Prevalence of antinicleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases
    Putova, Ivana
    Dostal, C.
    Becvar, R.
    AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS, 2007, 1109 : 275 - 286
12345